Reider Paul — SEC Form 4 filings

SEC reporting owner CIK 1970033. 5 Form 4 filings on record with FilingPulse; latest filed 2025-01-22.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-01-23 to 2025-01-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Coherus BioSciences, Inc. (CHRS)Chief Commercial Officer56

Form 4 filings — Reider Paul

FiledFormIssuerReported transactionsSource
2025-01-224Coherus BioSciences, Inc. (CHRS)Tax withholding (F): 4,858 @ $1.39EDGAR
2025-01-074Coherus BioSciences, Inc. (CHRS)Tax withholding (F): 2,277 @ $1.66 · Grant/award (A): 160,000 (derivative) @ $0EDGAR
2024-12-174Coherus BioSciences, Inc. (CHRS)Tax withholding (F): 2,073 @ $1.61EDGAR
2024-07-244Coherus BioSciences, Inc. (CHRS)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-01-234Coherus BioSciences, Inc. (CHRS)Tax withholding (F): 4,854 @ $2.44EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1970033 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →